Why Monsanto Earnings Will Not Please Investors
June 24, 2015 by Paul Ausick
Monsanto Co. (NYSE: MON) reported fiscal third-quarter 2015 results before markets opened Wednesday morning. The fertilizer and seed maker reported adjusted diluted earnings per share (EPS) of $2.39 on revenue of $4.58 billion. In the same period a year ago, Monsanto reported EPS of $1.62 on revenue of $4.25 billion. Third-quarter results also compare to the Thomson Reuters consensus estimates for EPS of $2.07 and $4.61 billion in revenue.
Monsanto reaffirmed its fiscal year 2015 EPS guidance “at the low end of the range” of $5.75 to $6.00. Full-year EPS also continues to be expected at the low end of a range of $5.80 to $6.05 per share. The company reaffirmed its previous forecasts for free cash flow at the low end of its previously stated range of $2.0 billion to $2.2 billion and net cash from operating activities in the range of $3.0 billion to $3.3 billion.
The company now expects fourth-quarter results to be “break-even.” The current consensus EPS estimate for the fourth quarter is $0.31, compared with a loss of $0.27 per share a year ago. The consensus estimate for full-year EPS is $5.77 and revenues are estimated at $15.58 billion.
The company’s CEO said:
The challenges facing the world’s food supply continue to evolve. The growing population, along with our volatile and changing climate, place ever-increasing burdens on sustainable global food production. Equipping farmers with the right set of innovations that will help solve tomorrow’s food challenges today requires more than a new company — it requires a new vision and approach.
The CEO also called Monsanto’s proposed $45 billion acquisition of Syngenta A.G. (NYSE: SYT) “an exciting logical next step for our business, offering the opportunity to accelerate innovation and support a more diverse group of farmers around the world.” Syngenta is less enthusiastic, having rejected the offer again on Tuesday. Still, the potential merger remains top-of-mind for investors who, as long as Monsanto does not completely tank the stock price, probably will not suffer too much.
ALSO READ: How to Protect Yourself From a Summer Stock Market Correction
Monsanto’s shares traded down more than 2% just after Wednesday’s opening bell, at $110, in a 52-week range of $105.76 to $128.79. Thomson Reuters had a consensus analyst price target of around $136.00 before the earnings report.
Take This Retirement Quiz To Get Matched With A Financial Advisor (Sponsored)
Take the quiz below to get matched with a financial advisor today.
Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests.
Here’s how it works:
1. Answer SmartAsset advisor match quiz
2. Review your pre-screened matches at your leisure. Check out the advisors’ profiles.
3. Speak with advisors at no cost to you. Have an introductory call on the phone or introduction in person and choose whom to work with in the future
Take the retirement quiz right here.